한글목차

바이오시뮬레이션 세계 시장 규모는 2025년에는 27억 7,700만 달러, 2032년에는 86억 8,990만 달러에 달할 것으로 예상되며, 2025년부터 2032년까지 연평균 성장률(CAGR)은 17.7%에 달할 것으로 예상됩니다.

그림. 바이오시뮬레이션 시장 점유율(%), 지역별, 2025년

바이오시뮬레이션은 컴퓨터 시뮬레이션을 사용하여 인체의 생물학적 과정, 시스템, 경로를 시뮬레이션하는 데 사용되는 계산 모델입니다. 인체가 분자 및 세포 수준에서 어떻게 작동하는지, 약물이나 의료기기와 같은 특정 의료 개입이 어떻게 작용하는지 이해하는 데 도움이 됩니다. 분자 수준에서 조직 수준까지 다양한 스케일에서 질병의 메커니즘과 진행, 치료 개입과의 상호작용을 시뮬레이션함으로써, 바이오시뮬레이션은 의약품 개발 과정에서 대규모 실험실 검사 및 임상 검사의 필요성을 줄이는 데 도움이 됩니다. 이를 통해 비용 절감, 효율성 향상, 신약 개발의 신속화를 실현할 수 있습니다.

시장 역학

세계 바이오시뮬레이션 시장의 성장은 제약 및 생명공학 산업의 R&D 비용 증가, 의약품 개발 비용 및 개발 기간 단축에 대한 중요성 증가, 맞춤형 의료의 채택 증가, 만성질환의 유병률 증가, 바이오시뮬레이션 부문의 급속한 기술 발전 등의 요인에 기인합니다.에 의해 초래됩니다. 그러나 복잡한 바이오시뮬레이션 도구와 모델을 다루는 데 필요한 유능한 IT 인프라와 숙련된 전문가의 부족으로 인해 시장 성장이 제한될 수 있습니다. 이 시장의 주요 비즈니스 기회는 백신 개발, 식이 및 독성 분석, 조직 공학, 맞춤형 의료 등 바이오시뮬레이션의 응용 분야 확대와 기술 발전을 위한 산-학 간의 지속적인 협력에 있습니다.

세계 바이오시뮬레이션 시장은 최근 몇 년 동안 괄목할 만한 기술 발전을 이루었으며, 이로 인해 새로운 기회와 응용 분야가 생겨나고 있습니다. 바이오시뮬레이션은 컴퓨터 모델링과 시뮬레이션을 사용하여 생물학적 과정을 연구하고 예측하는 것입니다. 이를 통해 연구자들은 세포, 조직, 생물체 전체와 같은 생물학적 시스템을 시뮬레이션하여 질병을 더 잘 이해하고 새로운 치료법을 테스트할 수 있습니다.

본 조사의 주요 특징

• 세계의 바이오시뮬레이션 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년)의 시장 규모와 연평균 성장률(CAGR)에 대해 조사 분석하여 전해드립니다.
• 또한, 다양한 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 바이오시뮬레이션 시장의 주요 기업을 프로파일링합니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계 바이오시뮬레이션 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 바이오시뮬레이션 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사 목적과 가정

• 조사 목적
• 가정
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• 영향 분석
• 규제 시나리오
• 제품 발매/승인
• PEST 분석
• Porters 분석
• 인수합병 시나리오

제4장 세계의 바이오시뮬레이션 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측 분석
• 경제에 대한 영향

제5장 세계의 바이오시뮬레이션 시장, 제품 및 서비스별, 2020-2032년

• 소개
• 소프트웨어
• 서비스

제6장 세계의 바이오시뮬레이션 시장, 용도별, 2020-2032년

• 소개
• Drug Discovery
• 의약품 개발

제7장 세계의 바이오시뮬레이션 시장, 유통 채널별, 2020-2032년

• 소개
• 병원 약국
• 소매 약국
• 온라인 약국

제8장 세계의 바이오시뮬레이션 시장, 지역별, 2020-2032년

• 소개
• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제9장 경쟁 구도

• Certara, L.P.
• Simulations Plus, Inc.
• Dassault Systemes(Accelrys)
• Genedata AG
• LeadScope, Inc.
• Compugen Inc.
• Schrodinger, LLC
• In Silico Biosciences, Inc.
• Advanced Chemistry Development, Inc.
• Chemical Computing Group ULC
• Physiomics PLC
• Pharmaceutical Product Development, LLC(Evidera)

제10장 섹션

• 조사 방법
• 출판사 소개

영문목차

Global Biosimulation Market is estimated to be valued at USD 2,777. Mn in 2025 and is expected to reach USD 8,689.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 17.7% from 2025 to 2032.

Figure. Biosimulation Market Share (%), By Region 2025

Biosimulation is a computational model that is used to simulate biological processes, systems, and pathways of the human body using computer simulations. It aids in understanding how the body functions at molecular and cellular levels and how certain medical interventions such as drugs or medical devices are likely to behave in it. By simulating disease mechanisms, progressions and their interaction with therapeutic interventions at various scales from molecule to tissue, biosimulation aids in reducing the need for extensive laboratory and clinical testing during drug development processes. This leads to lower costs, greater efficiency, and faster drug discovery.

Market Dynamics:

Global biosimulation market growth is driven by factors such as rising R&D expenditure in pharmaceutical and biotechnology industries, growing emphasis on reducing drug development costs and time, increasing adoption of personalized medicine, growing prevalence of chronic diseases, and rapid technological advancements in field of biosimulation. However, the market growth can be restrained due to lack of competent IT infrastructure and skilled professionals required for handling complex biosimulation tools and models. Major opportunity for this market lies in growing application areas of biosimulation including vaccine development, dietary and toxicity analysis, tissue engineering, personalized medicine, and others and ongoing collaborations between industries and academic institutions for further advancement of technology.

Global biosimulation market has witnessed tremendous technological progress in the recent years, and this offers new opportunities and applications. Biosimulation uses computer modeling and simulation to study and predict biological processes. It allows researchers to simulate biological systems like cells, tissues and entire organisms to better understand disease and test new drug treatments.

Key features of the study:

• This report provides in-depth analysis of the global biosimulation market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global biosimulation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Certara, L.P., Simulations Plus, Inc., Dassault Systemes (Accelrys), Genedata AG, LeadScope, Inc., Compugen Inc., Schrodinger, LLC, In Silico Biosciences, Inc., Advanced Chemistry Development, Inc., Chemical Computing Group ULC, Physiomics PLC, and Pharmaceutical Product Development, LLC (Evidera)
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global biosimulation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biosimulation market

Biosimulation Market Detailed Segmentation:

• By Product and Services
  • Software
  • Services
• By Application
  • Drug Discovery
  • Drug Development
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Certara, L.P.
  • Simulations Plus, Inc.
  • Dassault Systemes (Accelrys)
  • Genedata AG
  • LeadScope, Inc.
  • Compugen Inc.
  • Schrodinger, LLC
  • In Silico Biosciences, Inc.
  • Advanced Chemistry Development, Inc.
  • Chemical Computing Group ULC
  • Physiomics PLC
  • Pharmaceutical Product Development, LLC (Evidera)

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Biosimulation Market Snippet, By Product and Services
  • Global Biosimulation Market Snippet, By Application
  • Global Biosimulation Market Snippet, By Distribution Channel
  • Global Biosimulation Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Biosimulation Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Biosimulation Market, By Product and Services, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Software
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
• Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

6. Global Biosimulation Market, By Application, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Drug Discovery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
• Drug Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

7. Global Biosimulation Market, By Distribution Channel, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

8. Global Biosimulation Market, By Region, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Mn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Certara, L.P.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Simulations Plus, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Dassault Systemes (Accelrys)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Genedata AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• LeadScope, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Compugen Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Schrodinger, LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• In Silico Biosciences, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Advanced Chemistry Development, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Chemical Computing Group ULC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Physiomics PLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Pharmaceutical Product Development, LLC (Evidera)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us